NCT04157985 2025-12-11
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
Phase 3 Completed
University of Pittsburgh
Genentech, Inc.
Cambridge University Hospitals NHS Foundation Trust
Celldex Therapeutics